Pillyze

AI-powered hyper-personalized health management for diet, blood sugar, exercise and supplements

Seoul, South Korea · Founded 2021 · $11.3M raised

Headquarters
Seoul
Employees
11–50
Founded
2021
Business Model
B2C
Total Funding
$11.3M
Last Round
$9.0M Series AAug 2023
Rounds
2

About

Pillyze is a South Korean AI-powered hyper-personalized health management platform that has surpassed 1.2 million cumulative users. The app enables users to manage diet, blood sugar, exercise, weight, and supplements in one place, delivering personalized coaching through an AI health coach available 24 hours a day. Key features include meal logging via food photos, real-time blood glucose monitoring via continuous glucose sensors, 10-year health checkup record tracking across 21 health items, AI-driven supplement analysis across a database of 20,000+ products, and integration with Samsung Health, Apple Health, and InBody devices. Pillyze is backed by verified institutions including the Korean Ministry of Food and Drug Safety, EFSA, NIH, and major Korean nutrition associations.

Summary

Pillyze is an Artificial Intelligence company based in Seoul, South Korea, founded in 2021. It has raised $11.3M in total across 2 rounds, most recently a $9.0M Series A round in Aug 2023. Investors include KB Investment, Korean Development Bank and Samsung Next.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AAug 2023
$9.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies